Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibroblast Growth Factor-23 Reduction in Predialysis Chronic Kidney Disease

NCT00843349 is registered in ClinicalTrials.gov with Myles Wolf as lead sponsor.

NCT NCT00843349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00843349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibroblast Growth Factor-23 Reduction in Predialysis Chronic Kidney Disease
Lead sponsor
Myles Wolf
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2009
Completion date
March 31, 2012
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease